Basic Fibroblast Growth Factor Improved Angiogenesis of Vitrified Human Ovarian Tissues after in vitro Culture and Xenotransplantation

Cryo Letters. 2017 May/Jun;38(3):194-201.

Abstract

Background: Basic fibroblast growth factor is a potent angiogenic factor.

Objective: To study the concentration and in vitro culture time of bFGF that maximize the angiogenesis for transplanted human ovarian tissues.

Materials and methods: Vitrified and rewarmed human ovarian tissues were cultured in vitro with bFGF (0, 25, 50, 100, 150 and 200 ng/ml) for different periods (1 h, 2 d, 5 d and 7 d) before transplantation. The effect of bFGF on follicle survival was studied by evaluating the pregraft group, control group (no bFGF) and bFGF-treated group. CD34, Ki-67 and AC-3 immuno-histochemical (IHC) staining and histological analysis was used to evaluate angiogenesis, proliferration, apoptosis and follicular quantity.

Results: Treatments with 100 and 150 ng/ml bFGF improved the angiogenesis for grafted human ovarian tissues after in vitro culture for 2 days. The proliferation and survival of follicles were significantly increased.

Conclusion: bFGF improved the quality of vitrified-warmed human ovarian tissues after transplantation.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Female
  • Fibroblast Growth Factor 2 / pharmacology*
  • Heterografts
  • Humans
  • Mice
  • Neovascularization, Pathologic / drug therapy*
  • Ovary / blood supply*
  • Ovary / drug effects
  • Ovary / transplantation*
  • Transplantation, Heterologous
  • Vitrification

Substances

  • Fibroblast Growth Factor 2